Search research articles
Contact Us
Filters
Showing results (41-50 of 140) with videos related to
Page
of 14
Sort By:
Journal of Hepatology
|
June 1, 2022
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
Sun Yoo, Ji Yoon Kim, Young-Suk Lim, et al.
Journal of Cardiovascular Pharmacology
|
October 10, 2017
Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
Jonggi Choi, Junhwan Kim, Ju Hyun Shim, et al.
Journal of Medical Virology
|
February 6, 2026
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
Jiwon Yang, Jihye Lim, Ye-Jee Kim, et al.
Annals of Hepatology
|
April 21, 2017
Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis
Roongruedee Chaiteerakij, Piyanat Chattieng, Jonggi Choi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 25, 2025
Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
Jiwon Yang, Jihye Lim, Ye-Jee Kim, et al.
Journal of Korean Medical Science
|
April 14, 2026
Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study
Jihye Lim, Jiwon Yang, Ye-Jee Kim, et al.
JHEP Reports : Innovation in Hepatology
|
October 1, 2025
Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia
Jiwon Yang, Sun Young Yim, Kunhee Kim, et al.
The Journal of Clinical Investigation
|
March 31, 2022
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
Gi-Ae Kim, Seungbong Han, Gwang Hyeon Choi, et al.
Alimentary Pharmacology & Therapeutics
|
May 29, 2019
High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi-Ae Kim, Jonggi Choi, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 140) with videos related to
Sort By:
Page
of 14
Journal of Hepatology
|
June 1, 2022
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
Sun Yoo, Ji Yoon Kim, Young-Suk Lim, et al.
Journal of Cardiovascular Pharmacology
|
October 10, 2017
Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
Jonggi Choi, Junhwan Kim, Ju Hyun Shim, et al.
Journal of Medical Virology
|
February 6, 2026
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
Jiwon Yang, Jihye Lim, Ye-Jee Kim, et al.
Annals of Hepatology
|
April 21, 2017
Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis
Roongruedee Chaiteerakij, Piyanat Chattieng, Jonggi Choi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 25, 2025
Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
Jiwon Yang, Jihye Lim, Ye-Jee Kim, et al.
Journal of Korean Medical Science
|
April 14, 2026
Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study
Jihye Lim, Jiwon Yang, Ye-Jee Kim, et al.
JHEP Reports : Innovation in Hepatology
|
October 1, 2025
Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia
Jiwon Yang, Sun Young Yim, Kunhee Kim, et al.
The Journal of Clinical Investigation
|
March 31, 2022
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
Gi-Ae Kim, Seungbong Han, Gwang Hyeon Choi, et al.
Alimentary Pharmacology & Therapeutics
|
May 29, 2019
High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi-Ae Kim, Jonggi Choi, et al.
Page
of 14